Apimeds Pharmaceuticals US, Inc. (APUS): SCHEDULE 13D/A filed Mar 30, 2026

Name: Apimeds Pharmaceuticals US, Inc. SCHEDULE 13D/A (0001213900-26-035996)
Creator: Apimeds Pharmaceuticals US, Inc.
Published: 2026-03-30

Form type: SCHEDULE 13D/A
Filing date: Mar 30, 2026
Accession number: 0001213900-26-035996
Filer: Apimeds Pharmaceuticals US, Inc. (CIK 1894525)